Home › Funds › Saturn V Capital Management LP › CADL

Saturn V Capital Management LP position in CADL

CANDEL THERAPEUTICS INC · Health Care

Saturn V Capital Management LP reported holding 3,476,206 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$36.3M, representing 5.31% of its reported portfolio and ranking #8 among its reported holdings. Saturn V Capital Management LP has disclosed CADL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)3.48M sh
Reported value held$36.29M
Portfolio Weight5.31%
First reportedQ1 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's CADL position evolved

Saturn V Capital Management LP first disclosed a stake in CADL in Q1 2026 at 2,896,588 shares (US$14.2M). The position peaked in Q3 2026 at 3,476,206 shares, worth US$36.3M. Across 3 filings, Saturn V Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,476,206 shares valued at US$36.3M — an increase of 172,520 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.90M $14.19M New
Q2 2026 3.30M $34.03M Add
Q3 2026 3.48M $36.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CADL and 13F data

CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 74 other funds we track also report a position in CADL — the largest reported positions include ACORN CAPITAL ADVISORS, LLC (US$36.5M), Portolan Capital Management, LLC (US$36.0M), Sands Capital Alternatives, LLC (US$4.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CADL

All CADL fund holders →

FAQ

How long has Saturn V Capital Management LP held CADL?

Saturn V Capital Management LP has disclosed CADL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Saturn V Capital Management LP's current position in CADL?

As of Q3 2026, Saturn V Capital Management LP holds 3.48M shares of CADL (CANDEL THERAPEUTICS INC), valued at $36.29M, representing 5.31% of its reported portfolio and ranking #8.

Has Saturn V Capital Management LP been buying or selling CADL?

In the latest 13F filing (Q3 2026), Saturn V Capital Management LP increased its position in CADL. The position peaked in Q3 2026 at 3.48M shares.

Which other funds hold CADL?

Other major institutional holders of CADL include ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, Sands Capital Alternatives, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.